These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15371634)

  • 1. Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study.
    Lavigne JE; Shearer WT; Thompson B; Orav EJ; Starc TJ; Colan SD; Pignatelli R; O'Brien SE; Bezold L; LaRusa P; Easley KA; Cheng I; Duffy SA; Lipshultz SE;
    Cardiovasc Toxicol; 2004; 4(2):187-97. PubMed ID: 15371634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.
    Lipshultz SE; Wilkinson JD; Thompson B; Cheng I; Briston DA; Shearer WT; Orav EJ; Westphal JA; Miller TL; Colan SD;
    J Am Coll Cardiol; 2017 Oct; 70(18):2240-2247. PubMed ID: 29073951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of HAART in infants and children of HIV-infected mothers.
    Zareba KM; Lavigne JE; Lipshultz SE
    Cardiovasc Toxicol; 2004; 4(3):271-9. PubMed ID: 15470274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No relation between in-utero exposure to HAART and intrauterine growth retardation.
    Briand N; Mandelbrot L; Le Chenadec J; Tubiana R; Teglas JP; Faye A; Dollfus C; Rouzioux C; Blanche S; Warszawski J;
    AIDS; 2009 Jun; 23(10):1235-43. PubMed ID: 19424054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.
    Lipshultz SE; Williams PL; Wilkinson JD; Leister EC; Van Dyke RB; Shearer WT; Rich KC; Hazra R; Kaltman JR; Jacobson DL; Dooley LB; Scott GB; Rabideau N; Colan SD;
    JAMA Pediatr; 2013 Jun; 167(6):520-7. PubMed ID: 23608879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
    Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
    Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.
    Guerra V; Leister EC; Williams PL; Starc TJ; Lipshultz SE; Wilkinson JD; Van Dyke RB; Hazra R; Colan SD
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):621-7. PubMed ID: 26794032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
    van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
    J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.
    Jitratkosol MH; Sattha B; Maan EJ; Gadawski I; Harrigan PR; Forbes JC; Alimenti A; van Schalkwyk J; Money DM; Côté HC;
    AIDS; 2012 Mar; 26(6):675-83. PubMed ID: 22436539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
    Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
    Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).
    Lipshultz SE; Shearer WT; Thompson B; Rich KC; Cheng I; Orav EJ; Kumar S; Pignatelli RH; Bezold LI; LaRussa P; Starc TJ; Glickstein JS; O'Brien S; Cooper ER; Wilkinson JD; Miller TL; Colan SD
    J Am Coll Cardiol; 2011 Jan; 57(1):76-85. PubMed ID: 21185505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.